Where immune cells are located is critical for cancer immune therapy, a new study shows
An innovative new approach highlights the relevance of immune cells’ position within melanoma to inform on a...
TB and COVID-19, a joint battle?
On World TB Day 2022, we are looking at how researchers from the McGill International TB Centre at the RI-MUHC are working to raise awareness and to put an end to TB.
RI-MUHC team receives Discovery of the Year Award from Québec Science magazine
Jean-Jacques Lebrun’s team at the RI-MUHC has won the 2021 Québec Science Discovery of the Year Award...
Cecilia Costiniuk receives 2022 CAHR-CANFAR Excellence in Research Award
RI-MUHC researcher is committed to improving the lives of those living with HIV
RI-MUHC trainee honoured by the American Association for Cancer Research
Yasmine Benslimane is investigating how the female hormone estrogen influences the spread of colon cancer...
LSD, a future antianxiety pill?
A new study by Dr. Gabriella Gobbi reveals the neurobiological mechanisms by which LSD could relieve anxiety
BCG vaccine provides protection against influenza virus but not SARS-CoV-2
A new study led by RI-MUHC researchers reveals that the 100-year-old tuberculosis vaccine known as..
What’s the signature of a healthy heart?
Instead of treating the “average person,” the Courtois Cardiovascular Signature Program aims to treat every person as a unique individual
COVID-19: A close look at vaccine strategies used with older people in Quebec
A new study determines the maximum recommended interval between the first and second doses of mRNA...
Beyond basic research: Coming to grips with a rare disease experience
To honour Rare Disease Day on February 28, an RI-MUHC research trainee shares the perspective he gained as a patient